Logo image of CSGP

COSTAR GROUP INC (CSGP) Stock Fundamental Analysis

USA - NASDAQ:CSGP - US22160N1090 - Common Stock

80.6 USD
-0.55 (-0.68%)
Last: 10/7/2025, 6:20:03 PM
80.6 USD
0 (0%)
After Hours: 10/7/2025, 6:20:03 PM
Fundamental Rating

5

Taking everything into account, CSGP scores 5 out of 10 in our fundamental rating. CSGP was compared to 63 industry peers in the Real Estate Management & Development industry. CSGP has an average financial health and profitability rating. CSGP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CSGP was profitable.
In the past year CSGP had a positive cash flow from operations.
Each year in the past 5 years CSGP has been profitable.
CSGP had a positive operating cash flow in each of the past 5 years.
CSGP Yearly Net Income VS EBIT VS OCF VS FCFCSGP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

The Return On Assets of CSGP (0.99%) is better than 63.49% of its industry peers.
Looking at the Return On Equity, with a value of 1.21%, CSGP is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
Industry RankSector Rank
ROA 0.99%
ROE 1.21%
ROIC N/A
ROA(3y)3.37%
ROA(5y)3.48%
ROE(3y)4.11%
ROE(5y)4.33%
ROIC(3y)N/A
ROIC(5y)N/A
CSGP Yearly ROA, ROE, ROICCSGP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

CSGP has a Profit Margin of 3.57%. This is in the better half of the industry: CSGP outperforms 71.43% of its industry peers.
CSGP's Profit Margin has declined in the last couple of years.
CSGP's Operating Margin has declined in the last couple of years.
CSGP has a better Gross Margin (79.33%) than 92.06% of its industry peers.
In the last couple of years the Gross Margin of CSGP has remained more or less at the same level.
Industry RankSector Rank
OM N/A
PM (TTM) 3.57%
GM 79.33%
OM growth 3Y-80.23%
OM growth 5Y-63.35%
PM growth 3Y-30.42%
PM growth 5Y-25.78%
GM growth 3Y-0.84%
GM growth 5Y0.06%
CSGP Yearly Profit, Operating, Gross MarginsCSGP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

6

2. Health

2.1 Basic Checks

CSGP does not have a ROIC to compare to the WACC, probably because it is not profitable.
CSGP has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CSGP has been increased compared to 5 years ago.
Compared to 1 year ago, CSGP has an improved debt to assets ratio.
CSGP Yearly Shares OutstandingCSGP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CSGP Yearly Total Debt VS Total AssetsCSGP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CSGP has an Altman-Z score of 11.82. This indicates that CSGP is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 11.82, CSGP belongs to the best of the industry, outperforming 87.30% of the companies in the same industry.
A Debt/Equity ratio of 0.12 indicates that CSGP is not too dependend on debt financing.
CSGP has a better Debt to Equity ratio (0.12) than 76.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 11.82
ROIC/WACCN/A
WACC8.74%
CSGP Yearly LT Debt VS Equity VS FCFCSGP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 5.83 indicates that CSGP has no problem at all paying its short term obligations.
CSGP has a better Current ratio (5.83) than 88.89% of its industry peers.
CSGP has a Quick Ratio of 5.83. This indicates that CSGP is financially healthy and has no problem in meeting its short term obligations.
CSGP has a Quick ratio of 5.83. This is amongst the best in the industry. CSGP outperforms 92.06% of its industry peers.
Industry RankSector Rank
Current Ratio 5.83
Quick Ratio 5.83
CSGP Yearly Current Assets VS Current LiabilitesCSGP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

6

3. Growth

3.1 Past

CSGP shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.68%.
The Earnings Per Share has been decreasing by -6.71% on average over the past years.
The Revenue has grown by 12.18% in the past year. This is quite good.
The Revenue has been growing by 14.35% on average over the past years. This is quite good.
EPS 1Y (TTM)-5.68%
EPS 3Y-14.08%
EPS 5Y-6.71%
EPS Q2Q%13.33%
Revenue 1Y (TTM)12.18%
Revenue growth 3Y12.07%
Revenue growth 5Y14.35%
Sales Q2Q%15.27%

3.2 Future

CSGP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.96% yearly.
CSGP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.54% yearly.
EPS Next Y13.58%
EPS Next 2Y38.47%
EPS Next 3Y40.6%
EPS Next 5Y33.96%
Revenue Next Year16%
Revenue Next 2Y15.25%
Revenue Next 3Y14.69%
Revenue Next 5Y12.54%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CSGP Yearly Revenue VS EstimatesCSGP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
CSGP Yearly EPS VS EstimatesCSGP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 97.11, the valuation of CSGP can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as CSGP.
Compared to an average S&P500 Price/Earnings ratio of 27.76, CSGP is valued quite expensively.
The Price/Forward Earnings ratio is 58.39, which means the current valuation is very expensive for CSGP.
68.25% of the companies in the same industry are more expensive than CSGP, based on the Price/Forward Earnings ratio.
CSGP's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.21.
Industry RankSector Rank
PE 97.11
Fwd PE 58.39
CSGP Price Earnings VS Forward Price EarningsCSGP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

CSGP's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 171.76
CSGP Per share dataCSGP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as CSGP's earnings are expected to grow with 40.60% in the coming years.
PEG (NY)7.15
PEG (5Y)N/A
EPS Next 2Y38.47%
EPS Next 3Y40.6%

0

5. Dividend

5.1 Amount

CSGP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

COSTAR GROUP INC

NASDAQ:CSGP (10/7/2025, 6:20:03 PM)

After market: 80.6 0 (0%)

80.6

-0.55 (-0.68%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)07-22 2025-07-22/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners105.15%
Inst Owner Change0%
Ins Owners0.68%
Ins Owner Change-1.03%
Market Cap34.15B
Analysts80.83
Price Target98.84 (22.63%)
Short Float %4.09%
Short Ratio5.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)72.14%
Min EPS beat(2)27.68%
Max EPS beat(2)116.6%
EPS beat(4)4
Avg EPS beat(4)47.74%
Min EPS beat(4)13.92%
Max EPS beat(4)116.6%
EPS beat(8)7
Avg EPS beat(8)37.66%
EPS beat(12)11
Avg EPS beat(12)28.52%
EPS beat(16)15
Avg EPS beat(16)25.58%
Revenue beat(2)0
Avg Revenue beat(2)-1.23%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)-0.8%
Revenue beat(4)0
Avg Revenue beat(4)-1.5%
Min Revenue beat(4)-2.45%
Max Revenue beat(4)-0.8%
Revenue beat(8)0
Avg Revenue beat(8)-1.51%
Revenue beat(12)0
Avg Revenue beat(12)-1.63%
Revenue beat(16)0
Avg Revenue beat(16)-1.54%
PT rev (1m)1.13%
PT rev (3m)10.16%
EPS NQ rev (1m)-0.36%
EPS NQ rev (3m)-19.47%
EPS NY rev (1m)-0.52%
EPS NY rev (3m)-0.03%
Revenue NQ rev (1m)0.29%
Revenue NQ rev (3m)0.89%
Revenue NY rev (1m)0.75%
Revenue NY rev (3m)1.13%
Valuation
Industry RankSector Rank
PE 97.11
Fwd PE 58.39
P/S 11.71
P/FCF N/A
P/OCF 86.53
P/B 3.97
P/tB 8.54
EV/EBITDA 171.76
EPS(TTM)0.83
EY1.03%
EPS(NY)1.38
Fwd EY1.71%
FCF(TTM)0
FCFYN/A
OCF(TTM)0.93
OCFY1.16%
SpS6.88
BVpS20.3
TBVpS9.43
PEG (NY)7.15
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.99%
ROE 1.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.57%
GM 79.33%
FCFM N/A
ROA(3y)3.37%
ROA(5y)3.48%
ROE(3y)4.11%
ROE(5y)4.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3%
ROCE(5y)3.93%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-80.23%
OM growth 5Y-63.35%
PM growth 3Y-30.42%
PM growth 5Y-25.78%
GM growth 3Y-0.84%
GM growth 5Y0.06%
F-Score5
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA 5.52
Cap/Depr 211.14%
Cap/Sales 13.59%
Interest Coverage N/A
Cash Conversion 217.65%
Profit Quality N/A
Current Ratio 5.83
Quick Ratio 5.83
Altman-Z 11.82
F-Score5
WACC8.74%
ROIC/WACCN/A
Cap/Depr(3y)211.68%
Cap/Depr(5y)162.35%
Cap/Sales(3y)11.14%
Cap/Sales(5y)9.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.68%
EPS 3Y-14.08%
EPS 5Y-6.71%
EPS Q2Q%13.33%
EPS Next Y13.58%
EPS Next 2Y38.47%
EPS Next 3Y40.6%
EPS Next 5Y33.96%
Revenue 1Y (TTM)12.18%
Revenue growth 3Y12.07%
Revenue growth 5Y14.35%
Sales Q2Q%15.27%
Revenue Next Year16%
Revenue Next 2Y15.25%
Revenue Next 3Y14.69%
Revenue Next 5Y12.54%
EBIT growth 1Y-108.74%
EBIT growth 3Y-77.85%
EBIT growth 5Y-58.09%
EBIT Next Year3074.52%
EBIT Next 3Y338.64%
EBIT Next 5Y157.07%
FCF growth 1Y-100.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.15%
OCF growth 3Y-5.8%
OCF growth 5Y-3.03%